PA
ALT icon

Profund Advisors’s Altimmune ALT Stock Holding History

Profund Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Buy
103,141
+30,843
+43% +$131K 0.01% 716
2025
Q4 		$261K Buy
72,298
+38,586
+114% +$168K 0.01% 980
2025
Q3 		$127K Buy
33,712
+11,999
+55% +$46.3K ﹤0.01% 1020
2025
Q2 		$84K Sell
21,713
-8,046
-27% -$43.5K ﹤0.01% 974
2025
Q1 		$149K Sell
29,759
-791
-3% -$5.01K 0.01% 932
2024
Q4 		$220K Sell
30,550
-404
-1% -$3.09K 0.01% 959
2024
Q3 		$190K Sell
30,954
-9,807
-24% -$66.4K 0.01% 1062
2024
Q2 		$271K Sell
40,761
-94,081
-70% -$694K 0.01% 778
2024
Q1 		$1.37M Buy
+134,842
New +$1.37M 0.05% 270
2023
Q2 		– Sell
-93,919
Closed -$396K – 1073
2023
Q1 		$396K Buy
+93,919
New +$1.12M 0.02% 589

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Profund Advisors's ALT Position: Q1 2026 in Review

Profund Advisors increased its Altimmune (ALT) stake by 43% in Q1 2026, buying an estimated $131K and bringing the position to 103,141 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #716.

Profund Advisors first reported a position in ALT in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.37M in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Profund Advisors held 103,141 shares of Altimmune worth $318K as of Q1 2026.
  • Profund Advisors bought 30,843 Altimmune shares in Q1 2026, an estimated $131K.
  • Altimmune made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #716 holding.
  • Profund Advisors first reported a position in Altimmune in Q1 2023 and has held it in 10 quarters since.
  • Profund Advisors's Altimmune position peaked at $1.37M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.